Chloroquine, a cheap drug used in Africa for decades to cure malaria may treat COVID-19, even as Bayer set to donate potential coronavirus drug to U.S.

Chloroquine, a cheap drug used in Africa for decades to cure malaria may be able treat COVID-19, a study published in Nature has found.

The study found that “remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro.”

“Chloroquine shouldn’t be left out of the discussion of candidate COVID-19 therapies and may actually be leading the pack,” Raymond James wrote in a research note earlier this month, reported Axios.

“Early evidence suggests that chloroquine — an inexpensive anti-malarial drug — may work just as well, if not even better, than remdesivir, a drug owned by Gilead, which is undergoing clinical trials for treatment of the coronavirus,” Axios said.

In a scoop on Wednesday, Axios quoted a senior Health and Human Services official and another source as confirming that Pharma company Bayer will soon make a large donation to the U.S. government of a drug that has shown some promise in helping patients suffering from the novel coronavirus.

The report acknowledged that the world was still a very long way from having an approved, clinically tested treatment for the coronavirus, adding that it did not hurt to have a potential treatment on hand.

error: Alert: Share This Content !!

Adblock Detected

Please consider supporting us by disabling your ad blocker